Amphastar Pharmaceuticals, Inc. — Director's Dealing 2020

Jun 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2020-06-07

Reporting Person: Lee Howard (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-07	Common Stock	F	663	$19.52	Disposed	127418	Direct
2020-06-08	Common Stock	A	5851	—	Acquired	133269	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-08	Stock Option (right to buy)	$20.08	A	16004	Acquired	2028-06-08	Common Stock (16004)	Direct

Footnotes

F1: The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.

F2: The reported shares are represented by RSUs, all of which vest on June 8, 2021.

F3: All of the shares subject to the option vest on June 8, 2021.